(Updated - May 26, 2022 12:13 PM EDT)

Stifel analyst Paul Matteis downgraded Avadel Pharmaceuticals (NASDAQ: AVDL) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE